Investors / United States / Solas BioVentures
Solas BioVentures
Venture capital · Chattanooga, TN, United States · North America
Solas BioVentures is an early-stage venture capital firm that invests exclusively in the life science industry. It is based in Chattanooga, Tennessee, with a satellite office in Research Triangle Park, North Carolina, and describes its reach as worldwide.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiopharmaceuticalsmedical devicesdigital healthmedtech
Your fit with Solas BioVentures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSolas BioVentures lists 22 checked portfolio companies on its own site and is named in 1 funding round, 1 of them as lead. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Broadview Ventures, ARCH Venture Partners and Arboretum Ventures.
Counts come from funding rounds that name Solas BioVentures, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Solas BioVentures' whole history. Rounds on record name 1 company; its own site lists 22. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 57th | 23 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Broadview Ventures | 2 |
| ARCH Venture Partners | 1 |
| Arboretum Ventures | 1 |
| Better Ventures | 1 |
| Deep Future | 1 |
| Duke Capital Partners | 1 |
| IAG Capital Partners | 1 |
| Insight Partners | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2091%
- No longer answers00%
- Points to another company29%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Broadview Ventures
Compare Solas BioVentures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Solas BioVentures| Date | Company | Stage |
|---|---|---|
| 28 Jul 2026 | Seed Led |
Round details for Solas BioVentures
Amounts, full round histories and every co-investor in Solas BioVentures' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
22 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Arctx Medical develops therapy technology for acute pancreatitis and body temperature management | Healthcare & Biotech | Portfolio page | ||
| Arrivo Bio is developing first-of-its-kind medicines for hard-to-treat diseases | Healthcare & Biotech | Portfolio page | ||
| Aurenar develops an ear-worn device to reduce inflammation in intensive care unit patients | Healthcare & Biotech | Jul 2026Seed | Funding round | |
| Baebies develops and manufactures diagnostic testing platforms and tests for healthcare professionals and laboratory professionals. | Healthcare & Biotech | Portfolio page | ||
| Basking Biosciences is developing a targeted, highly specific, short-acting therapy with a direct-acting reversal agent to treat life-threatening clots | Healthcare & Biotech | Portfolio page | ||
| CardioNXT develops custom interfaces for next generation medical catheters and navigation systems | Healthcare & Biotech | Portfolio page | ||
| Cryosa is developing a treatment for obstructive sleep apnea (OSA) | Healthcare & Biotech | Portfolio page | ||
| Dimension Bio is a biotechnology company pioneering regenerative therapeutics | Healthcare & Biotech | Portfolio page | ||
| EirSystems provides medication management software for healthcare providers | Healthcare & Biotech | Portfolio page | ||
| Francis Medical develops therapies, including the Vanquish Water Vapor Ablation System, for treating prostate tissue | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
Healthcare & Biotech | Portfolio page | |||
| Ischemia Care is a diagnostics company engaged in development and commercialization of a breakthrough stroke blood testing platform | Healthcare & Biotech | Portfolio page | ||
| Knopp Biosciences manages a portfolio of future milestone payments and product royalties | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Pathware develops a real-time biopsy quality assessment system called Bioptic | Healthcare & Biotech | Portfolio page | ||
| Phenomics Health turns fragmented medication data into medication-response intelligence to help identify risk, optimize regimens, and learn from real-world response. | Healthcare & Biotech | Portfolio page | ||
| PreTel develops and provides labor monitoring systems for managing labor and improving maternal and neonatal outcomes | Healthcare & Biotech | Portfolio page | ||
| Stimdia is developing technology to help patients regain independent breathing and accelerate recovery from mechanical ventilation | Healthcare & Biotech | Portfolio page | ||
| Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- solasbio.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 28 Jul 2026
- Companies checked
- 22
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Solas BioVentures' profile as data
Pull Solas BioVentures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/solasbio.com
# also
GET /v1/firms/solasbio.com/portfolio
GET /v1/firms/solasbio.com/coinvestors
GET /v1/firms/solasbio.com/news